10 Best Healthcare Stocks to Buy with Highest Upside Potential

8. Roivant Sciences Ltd. (NASDAQ:ROIV)

Analyst Upside: 37.50%

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best healthcare stocks to buy with highest upside potential. Guggenheim lifted the price target on Roivant Sciences Ltd. (NASDAQ:ROIV) to $36 from $30 on May 26 and maintained a Buy rating on the shares, updating its model after the recent fiscal Q4 earnings and pipeline updates. The stock also received a rating update from Citi on May 21. The firm lifted the price target on Roivant Sciences Ltd. (NASDAQ:ROIV) to $42 from $35 and maintained a Buy rating on the shares. Citi stated that it sees further share upside on the company’s second half of 2026 data catalysts, and the stock remains a top pick at the firm following the IMVT-1402 data.

In its financial results for fiscal Q4 and full year ended March 31, 2026, Roivant Sciences Ltd. (NASDAQ:ROIV) reported that it has consolidated cash, cash equivalents, and marketable securities of $4.3 billion. It further stated that research and development expenses rose by $53.7 million to $198.9 million for the three months ended March 31, 2026, compared to $145.2 million for the three months ended March 31, 2025.

Roivant Sciences Ltd. (NASDAQ:ROIV) is involved in the biopharmaceutical business and engages in the development of transformative medicine. The company’s product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aim to treat psoriasis, thyroid eye disease, atopic dermatitis, and other illnesses.

1281292 - 11759070 - 1